The invention relates to compounds of the general formula (I), wherein the residues A, Het, R<;1>;, R<;2>; and R<;3>; have the meanings indicated in the description and the claims. The invention further relates to methods for producing said compounds and to the use of compounds of the general formula (I) as medicaments, especially as medicaments having a beta-amyloid inhibiting effect.